Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study
Abstract
OBJECTIVE: To evaluate the progression in time from euthyroidism to overt autoimmune hypothyroidism or to overt autoimmune hyperthyroidism. SUBJECTS AND METHODS: The design is that of a nested case-control study within the prospective Amsterdam autoimmune thyroid disease (AITD) cohort study in which 790 healthy euthyroid women with at least one first or second degree relative with documented AITD were followed for 5 years. Thyroid function tests were assessed annually. Contrast between cases (overt hypothyroidism - TSH>5.7 mU/l and free thyroxine (FT(4))<9.3 pmol/l and overt hyperthyroidism - TSH<0.4 mU/l and FT(4)>20.1 pmol/l, also referred to as events) and controls (matched for age and duration of follow-up). RESULTS: At baseline, the 38 hypothyroid cases had already higher TSH and lower FT(4) concentrations than their 76 controls, and the difference between both the groups persisted 1 year before occurrence of the event. In contrast, neither TSH nor FT(4) values differed between the 13 hyperthyroid cases and their 26 controls at baseline or 1 year before the event. The prevalence of thyroid peroxidase-Ab was higher in both hypothyroid and hyperthyroid cases than in controls. At the time of event, hypothyroid cases were less common among current smokers (P=0.083) and more common in the postpartum period (P=0.006) than their controls, whereas hyperthyroid cases were pregnant more frequently (P=0.063). CONCLUSIONS: The data suggest that progression toward overt autoimmune hypothyroidism is a gradual process taking several years, but in contrast overt autoimmune hyperthyroidism develops faster in terms of months.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the Amsterdam Autoimmune Thyroid Disease Study, the transition from subclinical hyperthyroidism to overt hyperthyroidism usually occurred within 1 year in patients younger than 65 years with autoimmune subclinical hyperthyroidism.
“In the prospective Amsterdam Autoimmune Thyroid Disease Study, which evaluated the 5-year natural history of SHyper in patients with GD, the transition from SHyper to overt hyperthyroidism usually occurred within 1 year in patients younger than 65 years with autoimmune SHyper [40] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [40]
Progression from subclinical hyperthyroidism to overt hyperthyroidism was more frequent after stress and pregnancy.
“This progression was more frequent after stress and pregnancy.”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [40]
The presence of thyroid antibodies is associated with an increased risk of progression from subclinical to overt hypothyroidism.
“The presence of thyroid antibodies, which is associated with an increased risk of progression from subclinical to overt hypothyroidism, suggests a closer monitoring of thyroid function in subjects with thyroid antibodies (27, 52).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [52]
The citation lists haven’t been fetched yet
References 40 · Cited by 99
- Authors
- Effraimidis, G., Strieder, T. G. A., Tijssen, J. G. P., & Wiersinga, W. M.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Effraimidis, Grigoris
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-01
- Volume
- 164
- Issue
- 1
- Pages
- 107-113
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2157413484
- Cited by
- 99
- References
- 40
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 6 · 2017: 8 · 2016: 5 · 2015: 4 · 2014: 7 · 2013: 10 · 2012: 13
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- autoimmune thyroid disease, autoimmune hypothyroidism, autoimmune hyperthyroidism, euthyroidism, disease progression, thyroid peroxidase antibodies, thyroid-stimulating hormone, free thyroxine, smoking, postpartum thyroid dysfunction, pregnancy, family history of thyroid disease, women
- MeSH terms
- Adult, Aged, Autoantibodies, Female, Graves Disease, Humans, Hyperthyroidism, Hypothyroidism, Iodine, Middle Aged, Netherlands, Pregnancy, Prospective Studies, Risk Factors, Smoking, Time Factors, Autoimmunity, Case-Control Studies, Smoking Cessation, Disease Progression, Genetic Predisposition to Disease, Hashimoto Disease, Postpartum Thyroiditis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review